Common Stock, Shares, Outstanding of Syros Pharmaceuticals, Inc. from 31 Dec 2015 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Syros Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 30 Sep 2024.
  • Syros Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2024 was 26,832,457, a 29% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Syros Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 26,832,457 +6,112,010 +29% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 26,809,764 +6,101,408 +29% 30 Jun 2024 10-Q 31 Jul 2024 2024 Q2
Q1 2024 26,728,337 +6,319,207 +31% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 26,448,678 +6,185,562 +31% 31 Dec 2023 10-Q 31 Oct 2024 2024 Q3
Q3 2023 20,720,447 +495,095 +2.4% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 20,708,356 -42,280,664 -67% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 20,409,130 -42,392,166 -68% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 20,263,116 +14,060,713 +227% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 20,225,352 -41,717,598 -67% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 62,989,020 +1,068,770 +1.7% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 62,801,296 +951,654 +1.5% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 6,202,403 -50,020,343 -89% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 61,942,950 +16,135,072 +35% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 61,920,250 +16,161,369 +35% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 61,849,642 +16,158,924 +35% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 56,222,746 +12,854,945 +30% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 45,807,878 +3,366,651 +7.9% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 45,758,881 +3,323,384 +7.8% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 45,690,718 +11,923,777 +35% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 43,367,801 +9,601,937 +28% 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 42,441,227 +8,795,742 +26% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 42,435,497 +8,814,442 +26% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 33,766,941 +1,530,514 +4.7% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 33,765,864 +7,342,489 +28% 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 33,645,485 +7,353,034 +28% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 33,621,055 +7,389,352 +28% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 32,236,427 +8,803,699 +38% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 26,423,375 +3,042,487 +13% 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q3 2017 26,292,451 +2,922,788 +13% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 26,231,703 +23,547,015 +877% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 23,432,728 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 23,380,888 +21,017,870 +889% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q3 2016 23,369,663 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 2,684,688 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q4 2015 2,363,018 31 Dec 2015 10-K 20 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.